Bridgeway Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $187K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $52.5K | Hold |
|
|||||
|
2022
Q4 | $38.2K | Sell |
|
|||||
|
2022
Q3 | $54K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $101K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $398K | Sell |
|
|||||
|
2019
Q4 | $1.48M | Sell |
|
|||||
|
2019
Q3 | $371K | Sell |
|
|||||
|
2019
Q2 | $349K | Hold |
|
|||||
|
2019
Q1 | $398K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $264K | Buy |
|
|||||
|
2018
Q2 | $133K | Hold |
|
|||||
|
2018
Q1 | $704K | Hold |
|
|||||
|
2017
Q4 | $588K | Hold |
|
|||||
|
2017
Q3 | $710K | Hold |
|
|||||
|
2017
Q2 | $704K | Hold |
|
|||||
|
2017
Q1 | $835K | Hold |
|
|||||
|
2016
Q4 | $826K | Sell |
|
|||||
|
2016
Q3 | $828K | Hold |
|
|||||
|
2016
Q2 | $410K | Buy |
|
|||||
|
2016
Q1 | $106K | Sell |
|
|||||
|
2015
Q4 | $187K | Hold |
|
|||||
|
2015
Q3 | $211K | Hold |
|
|||||
|
2015
Q2 | $104K | Buy |
|